LMR Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
LMR Partners's ACAD Position: Q3 2026 in Review
LMR Partners opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 176,000 shares worth $3.55M. The stake represents 0.01% of the portfolio and ranks #787 among its holdings. This is a return to the name: LMR Partners previously reported a position in ACAD as recently as Q3 2020.
LMR Partners first reported a position in ACAD in Q2 2016 and has held it in 5 quarters since. 350 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- LMR Partners held 176,000 shares of Acadia Pharmaceuticals worth $3.55M as of Q3 2026.
- Acadia Pharmaceuticals was a new LMR Partners position in Q3 2026.
- Acadia Pharmaceuticals made up 0.01% of LMR Partners's portfolio in Q3 2026, its #787 holding.
- LMR Partners first reported a position in Acadia Pharmaceuticals in Q2 2016 and has held it in 5 quarters since.
- 350 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.